Persephone Biosciences
YC W18San Diego, US · Founded 2017 · 6 employees · 7 known investors
Persephone Biosciences develops a synbiotic (probiotic and prebiotic combination) supplement for infants designed to replenish key beneficial gut bacteria. The product targets parents seeking to support their babies' digestive health, immune development, and overall microbiome health.
Founders & leadership· Y Combinator alumni (W18)
Investors · 7
In the news
- Persephone Biosciences Announces Positive Topline Results from ARTEMIS Clinical Trial of First-of-its-kind Synbiotic for Childrenfinance.yahoo.com · 2025
- 500+ Startups in Biotechnologyinsights.tryspecter.com · 2025
- Persephone Biosciences Secures $15M Seed Round to Transform Engineered Cell Therapeutics for Healthier Human Ecosystems | SignalBaseleadsontrees.com · 2025
- Persephone rakes in $15M to support country’s biggest cancer microbiome study - MedCity Newsmedcitynews.com · 2022
- Persephone Biosciences Closes $15M Seed Financing - FinSMEsfinsmes.com · 2022
- Persephone puts poop to work to explore and heal your gut microbiome – TechCrunchtechcrunch.com · 2022
- Persephone Biosciences - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2021